View in EDS

Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
Authors: Shi R; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Farnsworth DA; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Febres-Aldana CA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chow JLM; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Sheena R; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Atwal T; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Gomez Marti JL; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li S; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Thomas KN; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Lee CM; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Awrey SJ; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., McDonald PC; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada., Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dedhar S; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bennewith KL; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Lockwood WW; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada. wlockwood@bccrc.ca.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. wlockwood@bccrc.ca.
Source: Oncogene [Oncogene] 2025 Aug; Vol. 44 (32), pp. 2831-2849. Date of Electronic Publication: 2025 May 31.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40450112
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shi+R%22">Shi R</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Farnsworth+DA%22">Farnsworth DA</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Febres-Aldana+CA%22">Febres-Aldana CA</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chow+JLM%22">Chow JLM</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Sheena+R%22">Sheena R</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Atwal+T%22">Atwal T</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Gomez+Marti+JL%22">Gomez Marti JL</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Thomas+KN%22">Thomas KN</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Lee+CM%22">Lee CM</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Awrey+SJ%22">Awrey SJ</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22McDonald+PC%22">McDonald PC</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Somwar+R%22">Somwar R</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dedhar+S%22">Dedhar S</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ladanyi+M%22">Ladanyi M</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bennewith+KL%22">Bennewith KL</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Lockwood+WW%22">Lockwood WW</searchLink>; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada. wlockwood@bccrc.ca.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. wlockwood@bccrc.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2025 Aug; Vol. 44 (32), pp. 2831-2849. <i>Date of Electronic Publication: </i>2025 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40450112
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41388-025-03461-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2831
    Titles:
      – TitleFull: Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shi R
      – PersonEntity:
          Name:
            NameFull: Farnsworth DA
      – PersonEntity:
          Name:
            NameFull: Febres-Aldana CA
      – PersonEntity:
          Name:
            NameFull: Chow JLM
      – PersonEntity:
          Name:
            NameFull: Sheena R
      – PersonEntity:
          Name:
            NameFull: Atwal T
      – PersonEntity:
          Name:
            NameFull: Gomez Marti JL
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Thomas KN
      – PersonEntity:
          Name:
            NameFull: Lee CM
      – PersonEntity:
          Name:
            NameFull: Awrey SJ
      – PersonEntity:
          Name:
            NameFull: McDonald PC
      – PersonEntity:
          Name:
            NameFull: Somwar R
      – PersonEntity:
          Name:
            NameFull: Dedhar S
      – PersonEntity:
          Name:
            NameFull: Ladanyi M
      – PersonEntity:
          Name:
            NameFull: Bennewith KL
      – PersonEntity:
          Name:
            NameFull: Lockwood WW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5594
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 32
          Titles:
            – TitleFull: Oncogene
              Type: main
ResultId 1